InvestorsHub Logo
Followers 8
Posts 5219
Boards Moderated 0
Alias Born 09/16/2000

Re: Cytotekk post# 1903

Sunday, 07/09/2006 11:03:07 AM

Sunday, July 09, 2006 11:03:07 AM

Post# of 30974
This is from the most recent 10KSB, 22.6 million bucks from 10,000 Kollsman EVS units installed (they better get going, and they could with EVS2).

That makes the average royalties, (a three tiered agreement with the 200 free units already installed), of over $2,200 per unit, twice what the rumor mill is talking about,(although that rumor mill source is no longer an investor and was quite crabby about AVTX last time we communicated); from the last filing:

POTENTIAL IMPACT ON FINANCIAL PERFORMANCE

Advance Technologies Inc. under the terms of our exclusive license
with Kollsman Inc. is in a position to receive royalties of $22,640,000
over the initial 10,000 units sold under terms of this contract.
The
realization of these revenues is dependent upon Kollsman securing a major
share of the Enhanced Vision Market. Advance Technologies Inc. may or may
not achieve all or part of this royalty income based upon market
performance by Kollsman. The performance of Kollsman is subject to
external and internal factors at Kollsman which are outside of Advance
Technologies Inc. ability to either control, affect, or to predict. As
Kollsman progresses in the EVS market through the meeting of key
performance and sales milestones, Advance Technologies will report those
achievements as disclosed by Kollsman or reported in the public media.



Cytotekk,